Version 1
: Received: 28 December 2023 / Approved: 29 December 2023 / Online: 29 December 2023 (04:01:29 CET)
How to cite:
Guerrero, N.; Ayala, N.; Duran, N.; Cubides Munevar, A. M.; Botero Carvajal, A. Effects of Nonsteroid Anti-inflammatory Drugs on Pregnant Women and the Fetus: A Systematic Review of Literature. Preprints2023, 2023122247. https://doi.org/10.20944/preprints202312.2247.v1
Guerrero, N.; Ayala, N.; Duran, N.; Cubides Munevar, A. M.; Botero Carvajal, A. Effects of Nonsteroid Anti-inflammatory Drugs on Pregnant Women and the Fetus: A Systematic Review of Literature. Preprints 2023, 2023122247. https://doi.org/10.20944/preprints202312.2247.v1
Guerrero, N.; Ayala, N.; Duran, N.; Cubides Munevar, A. M.; Botero Carvajal, A. Effects of Nonsteroid Anti-inflammatory Drugs on Pregnant Women and the Fetus: A Systematic Review of Literature. Preprints2023, 2023122247. https://doi.org/10.20944/preprints202312.2247.v1
APA Style
Guerrero, N., Ayala, N., Duran, N., Cubides Munevar, A. M., & Botero Carvajal, A. (2023). Effects of Nonsteroid Anti-inflammatory Drugs on Pregnant Women and the Fetus: A Systematic Review of Literature. Preprints. https://doi.org/10.20944/preprints202312.2247.v1
Chicago/Turabian Style
Guerrero, N., Angela Mayerly Cubides Munevar and Alejandro Botero Carvajal. 2023 "Effects of Nonsteroid Anti-inflammatory Drugs on Pregnant Women and the Fetus: A Systematic Review of Literature" Preprints. https://doi.org/10.20944/preprints202312.2247.v1
Abstract
Currently, the use of medications during pregnancy in Latin America is common; studies with Latin American samples find that nearly 90% of pregnant women use some medication at least once during pregnancy. Furthermore, approximately 21% of the respondents self-medicated. Worldwide, the prevalence of this disease is 32%. The most common medications are nonsteroidal anti-inflammatory drugs and analgesics. Many of these drugs are available over the counter without a prescription. For this reason, a systematic review of the literature on the adverse effects on the woman and the fetus was performed.
Objective: To determine the adverse effects associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) on pregnant women and fetuses during pregnancy.
Methods: Systematic literature review. The following search strategy was used for the databases: Science Direct, PubMed, Scopus and Web of Science, through September 3, 2022. The population of pregnant women without previous comorbidities was defined. The intervention of interest was the use of NSAIDs during pregnancy. The outcomes of interest were adverse effects for the mother or fetus (weight of the newborn, congenital malformations present in the fetus, systemic effects in the pregnant woman during her gestation period). The types of studies included clinical trials, cohort studies and case‒control studies.
Results: 1 study included 2,985 pregnant women without previous comorbidities. The use of aspirin more frequently during pregnancy stands out. The adverse effects on the fetus were preterm birth <37 weeks, low birth weight < 2500 g and increased admission to the neonatal intensive care unit. No adverse effects were found for the mother.
Conclusions: There are not enough data indicating that the use of NSAIDs during pregnancy is safe. Some studies show that the use of NSAIDs during pregnancy could be related to problems in the development and growth of the fetus and health effects for the mother during pregnancy, so it is advisable to use these drugs under medical prescription and for the shortest possible time. in the gestation stage.
Medicine and Pharmacology, Pharmacology and Toxicology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.